P. R. Greipp, International staging system for multiple myeloma, J. Clin. Oncol, vol.23, pp.3412-3420, 2005.

R. A. Kyle, Review of 1027 patients with newly diagnosed multiple myeloma, Mayo Clin. Proc, vol.78, pp.21-33, 2003.

G. J. Morgan, B. A. Walker, and F. E. Davies, The genetic architecture of multiple myeloma, Nat. Rev. Cancer, vol.12, pp.335-348, 2012.

N. C. Munshi and H. Avet-loiseau, Genomics in multiple myeloma, Clin. Cancer Res, vol.17, pp.1234-1242, 2011.

H. Avet-loiseau, Prognostic significance of copy-number alterations in multiple myeloma, J. Clin. Oncol, vol.27, pp.4585-4590, 2009.

M. K. Samur, The shaping and functional consequences of the dosage effect landscape in multiple myeloma, BMC Genom, vol.14, p.672, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00903866

N. Bolli, Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups, Leukemia, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01808859

S. Robiou-du-pont, Genomics of multiple myeloma, J. Clin. Oncol, vol.35, pp.963-967, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01813387

J. Corre, N. Munshi, and H. Avet-loiseau, Genetics of multiple myeloma: another heterogeneity level?, Blood, vol.125, pp.1870-1876, 2015.

T. Bochtler, Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14), Blood, vol.117, pp.3809-3815, 2011.

W. J. Chng, Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling, Cancer Res, vol.67, pp.2982-2989, 2007.

W. J. Chng, A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS, Blood, vol.106, pp.2156-2161, 2005.

M. L. Chretien, Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?, Blood, vol.126, pp.2713-2719, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01813432

Y. Li, Classify hyperdiploidy status of multiple myeloma patients using gene expression profiles, PLoS One, vol.8, p.58809, 2013.

S. M. Prideaux, E. Conway-o'brien, and T. J. Chevassut, The genetic architecture of multiple myeloma, Adv. Hematol, p.864058, 2014.

W. J. Chng, Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations, Leukemia, vol.20, pp.807-813, 2006.

S. V. Rajkumar, R. A. Kyle, and F. K. Buadi, Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence, Mayo Clin. Proc, vol.85, pp.945-948, 2010.

S. V. Rajkumar, O. Landgren, and M. V. Mateos, Smoldering multiple myeloma, Blood, vol.125, pp.3069-3075, 2015.
URL : https://hal.archives-ouvertes.fr/hal-00557757

R. A. Kyle, Prevalence of monoclonal gammopathy of undetermined significance, N. Engl. J. Med, vol.354, pp.1362-1369, 2006.

R. A. Kyle, Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma, N. Engl. J. Med, vol.356, pp.2582-2590, 2007.

S. Manier, Genomic complexity of multiple myeloma and its clinical implications, Nat. Rev. Clin. Oncol, vol.14, pp.100-113, 2017.

N. Bolli, Heterogeneity of genomic evolution and mutational profiles in multiple myeloma, Nat. Commun, vol.5, p.2997, 2014.

L. Rasche, Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing, Nat. Commun, vol.8, p.268, 2017.

J. G. Lohr, Genetic interrogation of circulating multiple myeloma cells at single-cell resolution, Sci. Transl. Med, vol.8, pp.363-147, 2016.

A. Davis, R. Gao, and N. Navin, Tumor evolution: linear, branching, neutral or punctuated?, Biochim. Biophys. Acta Rev. Cancer, vol.1867, pp.151-161, 2017.

R. Kominami, A sensitive assay for detecting mutations resulting from unequal homologous recombination without phenotypic selection, Mutat. Res, vol.243, pp.133-139, 1990.

G. Yavas, M. Koyuturk, M. Ozsoyoglu, M. P. Gould, and T. Laframboise, An optimization framework for unsupervised identification of rare copy number variation from SNP array data, Genome Biol, vol.10, p.119, 2009.

L. Lopez-corral, The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells, Clin. Cancer Res, vol.17, pp.1692-1700, 2011.

A. Mikulasova, Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance, Eur. J. Haematol, vol.97, pp.568-575, 2016.

S. Sidana, Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method, Am. J. Hematol, vol.94, pp.424-430, 2019.